Australian Pancreatic Cancer Alliance
Research
Breakthroughs in pancreatic cancer research are desperately needed. With the lowest five-year survival rate of all cancers in Australia (6.8%), it is shocking to think that these poor pancreatic cancer survival rates have not improved for thirty years.
Treatment
Treatment options for pancreatic cancer patients differ from patient to patient, and are based on several factors, including stage and location of cancer, the age of the patient, and general health.
Genetics
A number of gene mutations can increase your risk: Breast cancer gene 2 (BRAC2), Peutz-Jeghers Syndrome, Familial Atypical Mole Melanoma (FAMM), Hereditary Non-Polyposis Colorectal Cancer (HNPCC) and Familial Adenomatous Polyposis (FAP).
Symptoms
Early stages of pancreatic cancer often remain undetected due to lack of significant signs or symptoms. Symptoms are often not noticed until the cancer is large enough to affect nearby organs. .
Pancreatic Cancer Awareness
Breakthroughs in pancreatic cancer research are desperately needed. With the lowest five-year survival rate of all cancers in Australia (6.8%), it is shocking to think that these poor pancreatic cancer survival rates have not improved for nearly forty years.
We hope this site is a useful resource, helping you to find information about pancreatic cancer, research, support and other resources. You will also find information about how you can help raise much needed funds for Australian research into pancreatic cancer.
About the Pancreatic Cancer Alliance
The Pancreatic Cancer Alliance is a collaborative voice raising awareness of pancreatic cancer in Australia with a long-term view of increasing donor funds to support research. Members of the Pancreatic Cancer Alliance currently include (in alphabetical order): PanKind, The Australian Pancreatic Cancer Foundation; Cancer Australia; Garvan Institute of Medical Research; GI Cancer Institute; Pancare Foundation; Patron - Tracey Spicer, and #PurpleOurWorld.